[1]石红梅.人参归脾丸对缺铁性贫血患者HB、RBC、HCT的影响[J].西部中医药,2013,26(03):80-81.
　SHI Hongmei.Effect of RenShen GuiPiW an on HGB, RBC and HCT of Patients with Iron-deficiency Anemia[J].Western Journal of Traditional Chinese Medicine,2013,26(03):80-81.
点击复制

人参归脾丸对缺铁性贫血患者HB、RBC、HCT的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年03期
页码:
80-81
栏目:
出版日期:
2013-03-15

文章信息/Info

Title:
Effect of RenShen GuiPiW an on HGB, RBC and HCT of Patients with Iron-deficiency Anemia
文章编号:
1004-6852(2013)03-0080-02
作者:
石红梅
陇西县第一人民医院检验科，甘肃 陇西 748100
Author(s):
SHI Hongmei
Clinical Laboratory of Longxi County the First People's Hospital, Longxi 748100, China
关键词:
贫血; 缺铁性; 血红蛋白; 红细胞; 血细胞比容; 人参归脾丸
Keywords:
anemia;  iron-deficiency;  hemoglobin (HB);  red blood cell (RBC);  hematocrit (HCT); RenShen GuiPiWan
分类号:
R556.3
文献标志码:
B
摘要:
目的：观察人参归脾丸对缺铁性贫血(IDA)患者血红蛋白(HB)、红细胞(RBC)、血细胞比容(HCT)的影响。方法：将 80 例 IDA 患者随机分为观察组和对照组各 40 例。2 组均服用琥珀酸亚铁片，0.1 g/ 次，3 次 /d，同时每次给予等量维生素 C 同服以利吸收；观察组同时给予人参归脾丸，9 g/ 次，3 次 /d。2 组均以治疗 1 个月为 1 个疗程，治疗 1 个疗程后评价疗效。结果：治愈率观察组为 80.00%，对照组为 50.00%，2 组相比差异显著(P＜0.05)。总有效率观察组为 95.00%，对照组为 75.00%，2 组相比差异显著(P＜0.05)。HB、RBC、HCT治疗后 2 组均明显增高 (P＜0.05)，治疗后组间比较差异显著(P＜0.05)。结论：人参归脾丸可改善 IDA 患者HB、RBC、HCT 指标。
Abstract:
Objective: To verify the effects of RenShen GuiPiWan on hemoglobin (HB), red blood cell (RBC) and hematocrit (HCT) of patients suffering from iron-deficiency anemia. Method: Eighty patients were randomly separated into the observation group and the control group. Both groups took ferrous succinate tablets,0.1 g once, three times each day, and the same amounts of vitamin C to promote absorption; the observation group received RenShen GuiPiWan, 9 g once, three times each day. One course of treatment was one month, clinical effects were observed after treating for one course of treatment. Result: Cure rate of the observation group was 80.00%, higher than 50.00% of the control group with significant difference (P＜ 0.05). Total effective rates of the observation group and the control group were 95.00% and 75.00%, comparison between both groups demonstrated significant difference (P＜ 0.05). HB, RBC and HCT were improved of both groups after treating (P ＜ 0.05),comparison between both groups showed significant difference (P＜ 0.05). Conclusion: RenShen GuiPiWan could improve the indexes including HB, RBC and HCT.

参考文献/References:

［1］ 李迎春，王彪.缺铁性贫血的诊断和鉴别诊断［J］.中国实用乡村医生杂志，2008，15(6)：7-8. ［2］ 许文荣，王建中.临床血液学和血液学检验［M］.4 版.北京：人民卫生出版社，2007：7. ［3］ 张文龙，王曼萍，张骥，等.慢性病贫血的铁代谢研究［J］.临床血液学杂志，2008，21(6)：588-589. ［4］ 魏小平，马泽荣，郑贵星，等.骨髓铁与常用血清铁指标的相关性研究［J］.国际检验医学杂志，2011，32(14)：1546-1547. ［5］ 秦春优.中西医结合治疗小儿缺铁性贫血77例观察［J］.甘肃中医，2007，20（1）：29-30. ［6］ 张会云，田利军，高茉丽，等.中医治未病理论在小儿营养性缺铁性贫血预防中的应用［J］.河北中医，2011，33（7）：1016-1017.

相似文献/References:

[1]黄邦荣,张东鹏△.裴正学教授治疗再生障碍性贫血的经验[J].西部中医药,2013,26(07):37.
　HUANG Bangrong,ZHANG Dongpeng.Professor PEI Zhengxue′s Experience of Treating Aplastic Anemia[J].Western Journal of Traditional Chinese Medicine,2013,26(03):37.
[2]夏小军,段赟.中医药治疗自身免疫性溶血性贫血的思路与方法[J].西部中医药,2016,29(02):41.
　XIA Xiaojun,DUAN Yun.Thinking and Methods of TCM in the Treatment for Autoimmune Hemolytic Anemia[J].Western Journal of Traditional Chinese Medicine,2016,29(03):41.
[3]曾翠青,吴东明,段小军,等.足三里穴位注射重组人促红素治疗肾性贫血疗效观察[J].西部中医药,2022,35(09):126.[doi:10.12174/j.issn.2096-9600.2022.09.26]
　ZENG Cuiqing,WU Dongming,DUAN Xiaojun,et al.Clinical Observation on Zusanli Acupoint Injection of Recombinant Human Erythropoietin Injection in the Treatment of Renal Anemia[J].Western Journal of Traditional Chinese Medicine,2022,35(03):126.[doi:10.12174/j.issn.2096-9600.2022.09.26]
[4]侯敏娜,侯少平,逯莉,等.基于整合药理学平台的当归补血汤治疗贫血分子作用机制研究[J].西部中医药,2023,36(11):8.[doi:10.12174/j.issn.2096-9600.2023.11.02]
　HOU Minna,HOU Shaoping,LU Li,et al.Study on the Molecular Mechanism of Danggui Buxue Tang in Treating Anemia Based on TCMIP[J].Western Journal of Traditional Chinese Medicine,2023,36(03):8.[doi:10.12174/j.issn.2096-9600.2023.11.02]
[5]王玥,栗枭杰,吴朝旭,等.贫血对晚期胃癌患者预后及生活质量的影响[J].西部中医药,2023,36(11):101.[doi:10.12174/j.issn.2096-9600.2023.11.22]
　WANG Yue,LI Xiaojie,WU Chaoxu,et al.Influence of Anemia on the Prognosis and Quality of Life of Patients with Advanced Gastric Cancer[J].Western Journal of Traditional Chinese Medicine,2023,36(03):101.[doi:10.12174/j.issn.2096-9600.2023.11.22]

备注/Memo

备注/Memo:
收稿日期：2012-10-18 作者简介：石红梅(1970—)，女，主管检验师。研究方向：临床基础检验。
更新日期/Last Update: 2013-03-15